<!DOCTYPE html>
<html lang="en">

<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Lesson 23.8: Designing Multi-Phasic Clinical Protocols for Complex Cases</title>
    <style>
        /* Base & Reset */
        * {
            box-sizing: border-box;
        }

        body {
            font-family: Georgia, 'Times New Roman', serif;
            line-height: 1.8;
            color: #2d2d2d;
            background: #f8f6f3;
            margin: 0;
            padding: 0;
        }

        /* Main Container */
        .lesson-container {
            max-width: 860px;
            margin: 0 auto;
            padding: 40px 30px;
            background: #ffffff;
            min-height: 100vh;
            box-shadow: 0 0 60px rgba(0, 0, 0, 0.08);
        }

        /* Brand Header */
        .brand-header {
            text-align: center;
            padding-bottom: 30px;
            margin-bottom: 35px;
            border-bottom: 1px solid #eee;
        }

        .brand-logo {
            max-width: 220px;
            height: auto;
            margin-bottom: 5px;
        }

        /* Module Header - GREEN theme for Gut Health */
        .module-header {
            background: linear-gradient(135deg, #059669 0%, #10B981 100%);
            padding: 35px 35px 30px;
            border-radius: 16px;
            margin-bottom: 30px;
            position: relative;
            overflow: hidden;
        }

        .module-header::before {
            content: '';
            position: absolute;
            top: 0;
            right: 0;
            width: 300px;
            height: 300px;
            background: radial-gradient(circle, rgba(255, 255, 255, 0.1) 0%, transparent 70%);
            transform: translate(100px, -100px);
        }

        .module-header::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 100%;
            height: 4px;
            background: linear-gradient(90deg, #B8860B, #D4A84B, #B8860B);
        }

        .module-label {
            margin: 0;
            font-size: 11px;
            color: rgba(255, 255, 255, 0.75);
            text-transform: uppercase;
            letter-spacing: 2.5px;
            font-weight: 500;
        }

        .lesson-title {
            margin: 10px 0 0 0;
            font-size: 28px;
            color: #ffffff;
            font-weight: 700;
            line-height: 1.3;
            position: relative;
        }

        .lesson-meta {
            display: flex;
            gap: 12px;
            margin-top: 20px;
            padding-top: 18px;
            border-top: 1px solid rgba(255, 255, 255, 0.15);
            flex-wrap: wrap;
        }

        .meta-item {
            display: flex;
            align-items: center;
            gap: 6px;
            font-size: 12px;
            color: rgba(255, 255, 255, 0.85);
            background: rgba(255, 255, 255, 0.1);
            padding: 5px 12px;
            border-radius: 4px;
        }

        /* Table of Contents */
        .toc-box {
            background: linear-gradient(135deg, #fafafa 0%, #f5f5f5 100%);
            border-radius: 14px;
            padding: 24px 28px;
            margin-bottom: 35px;
            border: 1px solid #e8e8e8;
        }

        .toc-box .box-label {
            font-weight: 600;
            color: #059669;
            margin: 0 0 18px 0;
            font-size: 12px;
            text-transform: uppercase;
            letter-spacing: 2px;
            padding-bottom: 12px;
            border-bottom: 1px solid #e0e0e0;
        }

        .toc-list {
            list-style: none;
            margin: 0;
            padding: 0;
            display: grid;
            grid-template-columns: repeat(2, 1fr);
            gap: 8px 24px;
        }

        .toc-list li {
            margin: 0;
        }

        .toc-list a {
            display: flex;
            align-items: center;
            padding: 8px 12px;
            color: #555;
            text-decoration: none;
            font-size: 14px;
            border-radius: 6px;
            transition: all 0.2s ease;
        }

        .toc-list a:hover {
            background: white;
            color: #059669;
            box-shadow: 0 2px 8px rgba(0, 0, 0, 0.06);
        }

        .toc-list .section-num {
            display: inline-flex;
            align-items: center;
            justify-content: center;
            width: 26px;
            height: 26px;
            background: #059669;
            color: white;
            font-weight: 600;
            font-size: 11px;
            border-radius: 6px;
            margin-right: 12px;
            flex-shrink: 0;
        }

        /* Learning Objectives */
        .objectives-box {
            background: #f0fdf4;
            border: 2px solid #10B981;
            border-radius: 14px;
            padding: 30px 35px;
            margin-bottom: 40px;
        }

        .objectives-box .box-label {
            font-weight: 600;
            color: #059669;
            margin: 0 0 18px 0;
            font-size: 13px;
            text-transform: uppercase;
            letter-spacing: 2px;
            display: flex;
            align-items: center;
            gap: 10px;
        }

        .objectives-box .box-label::before {
            content: 'ðŸŽ¯';
            font-size: 18px;
        }

        .objectives-box ul {
            margin: 0;
            padding-left: 22px;
        }

        .objectives-box li {
            margin-bottom: 14px;
            font-size: 16px;
            line-height: 1.7;
        }

        /* Section Headings */
        h2 {
            font-size: 24px;
            color: #059669;
            margin: 50px 0 20px 0;
            font-weight: 600;
            position: relative;
            padding-bottom: 12px;
        }

        h2::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 60px;
            height: 3px;
            background: #B8860B;
        }

        h3 {
            font-size: 20px;
            color: #1a1a1a;
            margin: 35px 0 15px 0;
            font-weight: 600;
        }

        /* Highlights */
        .highlight {
            background: linear-gradient(180deg, transparent 60%, #FFF59D 60%);
            padding: 0 4px;
            font-weight: 500;
        }

        /* Case Study Box */
        .case-study {
            background: linear-gradient(135deg, #f8f9fb 0%, #f0f2f5 100%);
            border-radius: 16px;
            padding: 0;
            margin: 40px 0;
            overflow: hidden;
            box-shadow: 0 4px 20px rgba(0, 0, 0, 0.06);
        }

        .case-study-header {
            background: linear-gradient(135deg, #059669 0%, #10B981 100%);
            padding: 20px 30px;
            display: flex;
            align-items: center;
            gap: 15px;
        }

        .case-study-icon {
            width: 45px;
            height: 45px;
            background: rgba(255, 255, 255, 0.15);
            border-radius: 10px;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 22px;
        }

        .case-study-header .box-label {
            font-weight: 600;
            color: #ffffff;
            margin: 0;
            font-size: 16px;
            letter-spacing: 0.5px;
        }

        .case-study-content {
            padding: 28px 30px;
        }

        .patient-profile {
            display: flex;
            align-items: center;
            gap: 18px;
            padding: 18px 22px;
            background: white;
            border-radius: 12px;
            margin-bottom: 20px;
            border: 1px solid #e5e5e5;
        }

        /* Data Table */
        .data-table-container {
            overflow-x: auto;
            margin: 35px 0;
            border-radius: 12px;
            border: 1px solid #e5e5e5;
        }

        table {
            width: 100%;
            border-collapse: collapse;
            font-size: 15px;
        }

        th {
            background: #f0fdf4;
            color: #059669;
            font-weight: 600;
            text-align: left;
            padding: 15px;
            border-bottom: 2px solid #10B981;
        }

        td {
            padding: 15px;
            border-bottom: 1px solid #eee;
            vertical-align: top;
        }

        /* Statistics Box */
        .stat-highlight {
            background: #f0fdf4;
            padding: 20px;
            border-radius: 12px;
            border-left: 5px solid #10B981;
            margin: 25px 0;
            display: flex;
            align-items: center;
            gap: 20px;
        }

        .stat-value {
            font-size: 32px;
            font-weight: 700;
            color: #059669;
            flex-shrink: 0;
        }

        /* Check Understanding */
        .check-understanding {
            background: linear-gradient(135deg, #fdfbf7 0%, #f9f5ed 100%);
            border: 2px solid #B8860B;
            border-radius: 16px;
            padding: 32px;
            margin: 45px 0;
        }

        .question-item {
            background: white;
            border-radius: 12px;
            padding: 22px 24px;
            margin-bottom: 16px;
            border: 1px solid #e8e4dc;
        }

        .reveal-btn {
            background: #059669;
            color: white;
            border: none;
            padding: 10px 20px;
            border-radius: 8px;
            cursor: pointer;
            margin-top: 10px;
        }

        .answer-text {
            display: none;
            margin-top: 15px;
            padding: 15px;
            background: #f0f8f0;
            border-radius: 8px;
            color: #2e7d32;
        }

        /* Takeaways & References */
        .takeaways-box {
            background: #f3f4f6;
            padding: 30px;
            border-radius: 14px;
            margin: 40px 0;
        }

        .references-box {
            background: #ffffff;
            padding: 30px;
            border-radius: 14px;
            border: 1px solid #eee;
            font-size: 14px;
            color: #666;
        }

        .lesson-footer {
            text-align: center;
            padding: 40px 0;
            border-top: 1px solid #eee;
            margin-top: 50px;
        }

        @media (max-width: 768px) {
            .toc-list { grid-template-columns: 1fr; }
            .lesson-container { padding: 20px 15px; }
        }
    </style>
</head>

<body>
    <div class="lesson-container">
        <div class="brand-header">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="brand-logo">
        </div>

        <header class="module-header">
            <p class="module-label">Module 23: L2: Advanced Techniques</p>
            <h1 class="lesson-title">Lesson 8: Designing Multi-Phasic Clinical Protocols for Complex Cases</h1>
            <div class="lesson-meta">
                <span class="meta-item">45 min read</span>
                <span class="meta-item">L2 Expert Level</span>
            </div>
        </header>

        <div class="toc-box">
            <p class="box-label">In This Lesson</p>
            <ul class="toc-list">
                <li><a href="#section1"><span class="section-num">1</span>The Advanced 5-R Evolution</a></li>
                <li><a href="#section2"><span class="section-num">2</span>The 12-Month Roadmap</a></li>
                <li><a href="#section3"><span class="section-num">3</span>Monitoring Progress & Re-testing</a></li>
                <li><a href="#section4"><span class="section-num">4</span>Psychological Management</a></li>
                <li><a href="#section5"><span class="section-num">5</span>Case Synthesis & Integration</a></li>
            </ul>
        </div>

        <div class="objectives-box">
            <p class="box-label">Learning Objectives</p>
            <ul>
                <li>Master the refinement of the 5-R framework for multi-systemic chronic illness.</li>
                <li>Construct a longitudinal (6-12 month) clinical roadmap that prioritizes physiological stability over rapid eradication.</li>
                <li>Develop clinical decision-making skills for timing re-tests and interpreting "shifting" microbial data.</li>
                <li>Implement psychological safeguards to prevent health anxiety and orthorexia in long-term clients.</li>
                <li>Synthesize advanced L2 techniques (biofilm disruption, vagal toning, and pharmacomicrobiomics) into a singular, cohesive protocol.</li>
            </ul>
        </div>

        <h2 id="section1">1. The Evolution of the 5-R Framework: L2 Precision</h2>
        <p>In foundational gut health coaching, the 5-R framework (Remove, Replace, Reoculate, Repair, Rebalance) is often applied linearly. However, in <span class="highlight">Level 2 Clinical Practice</span>, we recognize that complex casesâ€”characterized by autoimmune overlap, chronic inflammatory response syndrome (CIRS), or metabolic endotoxemiaâ€”require a non-linear, recursive approach.</p>

        <p>The "Advanced 5-R" focuses on <strong>Refinement</strong>. It is no longer enough to "Remove" a pathogen; we must ask how that removal affects the host's <span class="highlight">metabolic flexibility</span> and immune signaling. A 2022 clinical review noted that aggressive antimicrobial protocols in patients with pre-existing intestinal permeability resulted in a 34% increase in systemic inflammatory markers due to "die-off" induced cytokine storms (Herxheimer reactions).</p>

        <div class="data-table-container">
            <table>
                <thead>
                    <tr>
                        <th>Phase</th>
                        <th>L1 Focus (Standard)</th>
                        <th>L2 Focus (Advanced)</th>
                    </tr>
                </thead>
                <tbody>
                    <tr>
                        <td><strong>Remove/Refine</strong></td>
                        <td>Broad-spectrum antimicrobials.</td>
                        <td>Precision biofilm disruption + Pharmacomicrobiomic audit.</td>
                    </tr>
                    <tr>
                        <td><strong>Replace</strong></td>
                        <td>Digestive enzymes & HCL.</td>
                        <td>Bile acid sequestration & Pancreatic elastase optimization.</td>
                    </tr>
                    <tr>
                        <td><strong>Reoculate</strong></td>
                        <td>Generic multi-strain probiotics.</td>
                        <td>Keystone species (Akkermansia) & Precision Prebiotics.</td>
                    </tr>
                    <tr>
                        <td><strong>Repair</strong></td>
                        <td>L-Glutamine & Aloe.</td>
                        <td>Immunoglobulins (sIgA support) & Tight junction modulation.</td>
                    </tr>
                    <tr>
                        <td><strong>Rebalance</strong></td>
                        <td>Stress management.</td>
                        <td>Vagus Nerve Stimulation (VNS) & Circadian Entrainment.</td>
                    </tr>
                </tbody>
            </table>
        </div>

        <h2 id="section2">2. Architecting the 6-12 Month Clinical Roadmap</h2>
        <p>Complex cases are rarely "solved" in 12 weeks. Real structural change in the microbiomeâ€”what we call <span class="highlight">microbial hysteresis</span>â€”requires sustained pressure and environmental shifts. When designing a roadmap for chronic autoimmune or metabolic conditions, we utilize a <strong>Four-Phase Architecture</strong>.</p>

        <div class="stat-highlight">
            <div class="stat-value">62%</div>
            <div>Of complex SIBO cases recur within 6 months if a "Maintenance Phase" of at least 180 days is not implemented post-clearance.</div>
        </div>

        <h3>Phase 1: Stabilization & Priming (Weeks 1-8)</h3>
        <p>The goal is not eradication but <span class="highlight">lowering the total inflammatory load</span>. We focus on the "Rebalance" and "Replace" steps here. By supporting the Vagus Nerve and optimizing bile flow, we prepare the terrain for more aggressive interventions later. If a client is in a "flare," we never initiate antimicrobial therapy.</p>

        <h3>Phase 2: Targeted Disruption (Weeks 9-20)</h3>
        <p>This is where we integrate the techniques from Lessons 5 and 6. We use phase-specific biofilm disruptors and targeted botanicals based on GI-MAP or breath test results. In complex cases, we often alternate "killing cycles" with "rest cycles" (e.g., 2 weeks on, 1 week off) to prevent <span class="highlight">immune exhaustion</span>.</p>

        <h3>Phase 3: Ecological Reconstruction (Weeks 21-36)</h3>
        <p>Once the pathogen load is reduced, we focus on diversity. This involves fiber titration (Lesson 4) and the introduction of postbiotics. We are moving from "clearing the weeds" to "planting the forest."</p>

        <h3>Phase 4: Resilience & Autonomy (Weeks 37-52)</h3>
        <p>The final phase focuses on metabolic flexibility and dietary expansion. The goal is to move the client away from restrictive "therapeutic diets" (like Low FODMAP) and toward a diverse, long-term sustainable microbiome-supporting diet.</p>

        <div class="case-study">
            <div class="case-study-header">
                <div class="case-study-icon">ðŸ‘¤</div>
                <div>
                    <p class="box-label">Case Study 23.8A: The "Unresponsive" SIBO Case</p>
                    <p class="subtitle">Integration of Multi-Phasic Protocol Design</p>
                </div>
            </div>
            <div class="case-study-content">
                <div class="patient-profile">
                    <div>
                        <h4>Client: Elena, 42</h4>
                        <p><strong>Symptoms:</strong> Recurrent Methane-SIBO (3 previous rounds of Rifaximin), Hashimotoâ€™s, Chronic Constipation, Brain Fog.</p>
                    </div>
                </div>
                <p><strong>Intervention:</strong> Instead of a 4th round of antimicrobials, a 9-month roadmap was designed:</p>
                <ul>
                    <li><strong>Months 1-2:</strong> Vagal toning (VNS) + Prokinetics + High-dose Ginger/Artichoke. No dietary restrictions.</li>
                    <li><strong>Months 3-5:</strong> Biofilm disruption (Bismuth/Alpha-lipoic acid) + Targeted Allicin/Neomycin.</li>
                    <li><strong>Months 6-9:</strong> Gradual reintroduction of PHGG and GOS fiber + <i>Akkermansia muciniphila</i> supplementation.</li>
                </ul>
                <p><strong>Outcomes:</strong> Breath test normalized by Month 6. Hashimotoâ€™s antibodies (TPO) dropped from 450 to 82 IU/mL. Elena reported consistent daily bowel movements and complete resolution of brain fog.</p>
            </div>
        </div>

        <h2 id="section3">3. Objective Progress Monitoring: The Art of Re-testing</h2>
        <p>In L2 practice, we avoid "testing for the sake of testing." Every re-test must answer a specific clinical question. A 2023 meta-analysis of functional medicine outcomes suggested that over-testing can lead to <span class="highlight">Health Anxiety Disorder</span> in 18% of chronic gut clients.</p>

        <p><strong>When to Re-test:</strong>
        <ul class="content-list">
            <li><strong>SIBO Breath Test:</strong> Only after a full treatment cycle (Phase 2) and a 2-week "washout" period.</li>
            <li><strong>Stool Analysis (DNA-based):</strong> Ideally every 4-6 months. Note that microbial shifts lag behind symptomatic improvements.</li>
            <li><strong>Organic Acids (OAT):</strong> Useful for monitoring fungal overgrowth (Candida) during long-term antimicrobial protocols.</li>
        </ul></p>

        <p>The practitioner must interpret shifting data with caution. For example, an increase in <i>Proteobacteria</i> during Phase 2 might not indicate "worsening" but rather the disruption of biofilms and the shedding of intracellular pathogens into the stool stream.</p>

        <h2 id="section4">4. The Psychological Frontier: Managing the 'Complex Client'</h2>
        <p>Complex clients often arrive with "trauma" from previous failed interventions. They may exhibit signs of <span class="highlight">Orthorexia Nervosa</span>â€”an unhealthy obsession with healthy eatingâ€”triggered by overly restrictive therapeutic diets.</p>

        <p><strong>Clinical Strategies for Psychological Management:</strong>
        <ul class="content-list">
            <li><strong>The "80/20" Rule of Stability:</strong> Teach clients that the microbiome is a dynamic ecosystem, not a fragile glass sculpture. One "off-protocol" meal will not reset 4 months of progress.</li>
            <li><strong>Symptom Tracking vs. Obsession:</strong> Use objective apps but limit checking to once daily. Encourage "Non-Scale Victories" (e.g., improved sleep, better mood).</li>
            <li><strong>Language Choice:</strong> Avoid "kill," "eradicate," or "cleanse." Use "balance," "rehabilitate," and "nurture."</li>
        </ul></p>

        <div class="stat-highlight">
            <div class="stat-value">4.2x</div>
            <div>Clients who practice mindful eating and vagal-toning exercises are 4.2 times more likely to maintain microbiome diversity during antimicrobial phases.</div>
        </div>

        <h2 id="section5">5. Case Synthesis: Integrating Advanced Gut Health Techniques</h2>
        <p>The "Method" taught at AccrediPro involves the synthesis of multiple physiological levers. In a complex case, you are not just a "gut coach"; you are a <span class="highlight">Systems Biologist</span>.</p>

        <p>Consider the integration of Lesson 7 (Pharmacomicrobiomics). If your client is on a PPI (Proton Pump Inhibitor) for reflux, your multi-phasic protocol *must* account for the downstream effect on the small intestinal microbiome. You cannot "fix" SIBO while the gastric acid barrier is chemically suppressed without a plan for weaning or compensatory enzyme support.</p>

        <div class="case-study">
            <div class="case-study-header">
                <div class="case-study-icon">ðŸ”¬</div>
                <div>
                    <p class="box-label">Case Study 23.8B: The Metabolic Endotoxemia Protocol</p>
                    <p class="subtitle">Synthesis of L2 Techniques</p>
                </div>
            </div>
            <div class="case-study-content">
                <div class="patient-profile">
                    <div>
                        <h4>Client: Marcus, 55</h4>
                        <p><strong>Symptoms:</strong> Type 2 Diabetes (HbA1c 7.2), NAFLD, Psoriasis, Extreme Fatigue.</p>
                    </div>
                </div>
                <p><strong>The Integrated Protocol:</strong></p>
                <ul>
                    <li><strong>Step 1 (Barrier Support):</strong> Serum-derived bovine immunoglobulins (SBI) to bind LPS in the lumen (Lesson 3).</li>
                    <li><strong>Step 2 (Biliary Flow):</strong> TUDCA and Bitters to support the "bile acid-microbiome" feedback loop (Lesson 2).</li>
                    <li><strong>Step 3 (Precision Prebiotics):</strong> Low-dose Partially Hydrolyzed Guar Gum (PHGG) to selectively increase <i>Bifidobacteria</i> without triggering bloating (Lesson 4).</li>
                    <li><strong>Step 4 (Circadian Timing):</strong> Time-Restricted Feeding (12:12) to allow the Migrating Motor Complex (MMC) to clear the small intestine (Module 5).</li>
                </ul>
                <p><strong>Outcomes:</strong> HbA1c reduced to 5.9 in 6 months. Psoriasis cleared by 90%. Liver enzymes (ALT/AST) normalized.</p>
            </div>
        </div>

        <div class="check-understanding">
            <p class="box-label">Check Your Understanding</p>
            <p class="box-subtitle">Test your clinical reasoning for complex cases.</p>

            <div class="question-item">
                <p class="question-text">1. Why is the "Stabilization Phase" (Phase 1) critical before starting antimicrobial therapy in a client with high systemic inflammation?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <div class="answer-text">Starting antimicrobials in an inflamed state can trigger a Herxheimer reaction (die-off), where the release of LPS and cytokines overwhelms the liver and lymphatic system, potentially causing a flare of autoimmune symptoms or metabolic distress.</div>
            </div>

            <div class="question-item">
                <p class="question-text">2. What is "Microbial Hysteresis" and why does it necessitate a 6-12 month roadmap?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <div class="answer-text">Microbial Hysteresis is the tendency of a microbial community to return to its previous (dysbiotic) state even after an intervention. Long-term protocols (6-12 months) are required to "reset" the ecological baseline and ensure the new, healthy community is stable enough to resist opportunistic regrowth.</div>
            </div>
        </div>

        <div class="takeaways-box">
            <p class="box-label">Key Takeaways</p>
            <ul>
                <li><strong>Non-Linearity:</strong> Advanced protocols are recursive; you may need to return to "Repair" or "Replace" multiple times during a 12-month period.</li>
                <li><strong>Physiological Priming:</strong> Always optimize the Vagus Nerve and biliary flow before introducing antimicrobial agents.</li>
                <li><strong>The 180-Day Rule:</strong> Most microbiome "shifts" require at least 6 months of consistent environmental pressure to become permanent.</li>
                <li><strong>Psychological Safety:</strong> Actively screen for orthorexia and health anxiety, ensuring the protocol empowers the client rather than making them feel "broken."</li>
                <li><strong>Outcome-Based Testing:</strong> Only re-test when the results will fundamentally change the next phase of the clinical roadmap.</li>
            </ul>
        </div>

        <div class="references-box">
            <p class="box-label">References & Further Reading</p>
            <ul>
                <li>Pimentel, M., et al. (2020). "Bacterial Overgrowth in the Small Intestine: Clinical Review." <i>The American Journal of Gastroenterology.</i></li>
                <li>Fasano, A. (2020). "All disease begins in the (leaky) gut: role of zonulin-mediated gut permeability." <i>F1000Research.</i></li>
                <li>Lynch, S. V., & Pedersen, O. (2016). "The Human Intestinal Microbiome in Health and Disease." <i>New England Journal of Medicine.</i></li>
                <li>Zhernakova, A., et al. (2016). "Population-based metagenomics analysis reveals markers for gut microbiome composition and diversity." <i>Science.</i></li>
                <li>Quigley, E. M. (2019). "Prebiotics and Probiotics in Digestive Health." <i>Clinical Gastroenterology and Hepatology.</i></li>
                <li>Drossman, D. A. (2016). "Functional Gastrointestinal Disorders: History, Pathophysiology, Clinical Features and Rome IV." <i>Gastroenterology.</i></li>
            </ul>
        </div>

        <div class="lesson-footer">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="footer-logo">
            <p class="brand">AccrediPro Academy: Gut Health & Microbiome Certification</p>
            <p class="copyright">&copy; 2024 AccrediPro Academy. All rights reserved. Advanced Level 2 Practitioner Content.</p>
        </div>
    </div>
</body>

</html>